These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3492485)

  • 21. Susceptibility of clinical isolates to cephalexin, cefazolin and cefotaxime.
    Gupta BL; Tahlan A; Dogra V; Rattan A; Bhujwala RA; Shriniwas
    Indian Pediatr; 1989 May; 26(5):466-71. PubMed ID: 2599615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum.
    Song HK; Oh JI; Kim MY; Kim YZ; Kim IC; Kwak JH
    J Antimicrob Chemother; 1996 Apr; 37(4):711-26. PubMed ID: 8722537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in mice.
    Yancey RJ; Kinney ML; Roberts BJ; Goodenough KR; Hamel JC; Ford CW
    Am J Vet Res; 1987 Jul; 48(7):1050-3. PubMed ID: 3631686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cefuzonam on peptidoglycan cross-linking reactions in gram-negative bacilli.
    Miyake Y; Okada M; Iseda S; Suginaka H
    Chemotherapy; 1992; 38(1):17-20. PubMed ID: 1617999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Todd PA
    Drugs; 1987 Aug; 34(2):188-221. PubMed ID: 3304966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
    Ravizzola G; Bonfanti C; Savoldi E; Turano A
    Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiological activity of cefazedone as compared to cefazolin and cephalothin.
    Knothe H
    Arzneimittelforschung; 1979; 29(2a):378-81. PubMed ID: 39575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]cephalosporin derivatives. V. Synthesis and antibacterial activity of 7 beta-[2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-cephalosporin derivates and related compounds.
    Ochiai M; Morimoto A; Miyawaki T; Matsushita Y; Okada T; Natsugari H; Kida M
    J Antibiot (Tokyo); 1981 Feb; 34(2):171-85. PubMed ID: 6271716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behaviour of cefmenoxime towards beta-lactamases.
    Labia R; Morand A; Ben Yaghlane H; Bryskier A
    Drugs Exp Clin Res; 1985; 11(6):373-8. PubMed ID: 3939122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftizoxime (FK 749) in vitro antibacterial activity.
    Husson MO; Courcol R; Izard D; Leclerc H
    Infection; 1984; 12(1):40-5. PubMed ID: 6323320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
    Bakhtiar M; Selwyn S
    Drugs Exp Clin Res; 1989; 15(10):477-82. PubMed ID: 2698794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on condensed-heterocyclic azolium cephalosporins. III. Synthesis and antibacterial activity of 7 beta-[2-(2-amino-5-substituted-thiazol-4-yl)-2 (Z)-alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl-3-cephem-4- carboxylates.
    Nishimura T; Yoshimura Y; Miyake A
    J Antibiot (Tokyo); 1992 Apr; 45(4):485-99. PubMed ID: 1592681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM; Turnidge JD;
    Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of cefepime compared with other antibiotics against gram-positive bacteria and cefuroxime-resistant gram-negative bacteria.
    Wang FD; Liu IM; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):408-13. PubMed ID: 9699393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
    Cullmann W; Dick W; Stieglitz M; Opferkuch W
    Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro antimicrobial activity of cefodizime, a third generation cephalosporin.
    Pruksachatvuthi S; Aswapokee N; Aswapokee P
    J Med Assoc Thai; 1992 May; 75(5):287-92. PubMed ID: 1460409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefmenoxime: in vitro activity.
    Stamm JM
    Am J Med; 1984 Dec; 77(6A):1-3. PubMed ID: 6097114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.